CVS Health Newsroom

CVS Health Faces Challenges: Hold Rating Due to Lower EPS Forecasts and Segment Pressures

TipRanksJul 9 06:19 ET

Evercore ISI Sticks to Their Buy Rating for CVS Health (CVS)

TipRanksJul 8 04:34 ET

Wolfe Research Adjusts Price Target on CVS Health to $64 From $70, Keeps Outperform Rating

MT NewswiresJun 13 06:10 ET

CVS Health Analyst Ratings

BenzingaJun 12 12:28 ET

CVS Health Analyst Ratings

BenzingaMay 30 14:17 ET

JP Morgan Maintains Overweight on CVS Health, Lowers Price Target to $86

BenzingaMay 30 14:17 ET

JPMorgan Adjusts Price Target on CVS Health to $86 From $101

MT NewswiresMay 30 07:52 ET

CVS Health (CVS) Receives a Hold From Wells Fargo

TipRanksMay 30 06:05 ET

CVS Health Analyst Ratings

BenzingaMay 30 05:54 ET

Wolfe Research Lowers CVS Health's Price Target to $64 From $70

MT NewswiresMay 28 13:37 ET

Buy Rating Affirmed: CVS Health's Proactive Strategies Counter Medicare Advantage Pressures and Unlock Growth Opportunities

TipRanksMay 15 06:01 ET

Argus Research Sticks to Its Buy Rating for CVS Health (CVS)

TipRanksMay 9 04:40 ET

Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)

TipRanksMay 8 22:35 ET

Argus Research Maintains Buy on CVS Health, Lowers Price Target to $80

BenzingaMay 8 12:07 ET

CVS Health Analyst Ratings

BenzingaMay 8 12:02 ET

Argus Research Adjusts Price Target on CVS Health to $80 From $100

MT NewswiresMay 8 08:00 ET

CVS Health Analyst Ratings

BenzingaMay 7 13:07 ET

Wells Fargo Adjusts CVS Health's Price Target to $60 From $76

MT NewswiresMay 7 06:37 ET

CVS Health Analyst Ratings

BenzingaMay 7 06:01 ET

HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91

MT NewswiresMay 3 05:30 ET